Holcim Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HCMLY research report →
Range $16.8 – $16.8
Price Chart
About the company
Holcim Ltd, a venerable company founded in 1833 and headquartered in Zug, Switzerland, functions as a global provider of construction materials and innovative solutions. Its expansive operations span across major regions, including Asia Pacific, Europe, Latin America, the Middle East, Africa, and North America. The company structures its business into four primary divisions: Cement, Aggregates, Ready-mix Concrete, and Solutions & Products.
- CEO
- Miljan Gutovic
- IPO
- 2010
- Employees
- 45,536
- HQ
- Zug, ZG, CH
Get TickerSpark's AI analysis on HCMLY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $43.23B
- P/E
- 61.96
- Fwd P/E
- 20.73
- PEG
- -0.80
- P/S
- 1.54
- P/B
- 2.30
- EV/EBITDA
- 8.46
- Div Yield
- 2.59%
- Gross Margin
- 42.03%
- Op Margin
- 15.90%
- Net Margin
- 2.47%
- ROE
- 3.74%
- ROIC
- 6.18%
Latest fiscal year · YoY change
- Revenue
- $15.72B-40.5%
- Gross Profit
- $6.66B-43.0%
- Op Income
- $2.23B
- Net Income
- $804.15M-72.5%
- EPS
- $4.77+359.5%
- OCF Growth
- -53.0%
- FCF Growth
- -58.9%
- 52W High
- $21.23
- 52W Low
- $15.36
- 50D MA
- $17.24
- 200D MA
- $18.22
- Beta
- 0.74
- RSI (14)
- 31
- Avg Volume
- 147.94K
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Holcim said first-half 2026 momentum accelerated in Q2, with strong organic sales and EBIT growth, and it raised full-year guidance while highlighting pricing discipline, margin expansion, and M&A integration.· July 31, 2026
- Organic net sales grew 5.2% in H1 and 6.4% in Q2; recurring EBIT rose 11.5% in H1 and 13.1% in Q2.
- EPS was up 7.4% in Swiss francs year over year; free cash flow is still guided at around CHF 2 billion for the full year.
- Management said price over cost was positive in all regions for the 17th consecutive quarter, with Q2 positive price over cost around EUR 90 million.
- The company upgraded 2026 guidance to the high end of its NextGen Growth 2030 targets: 5% organic net sales growth and 10% organic recurring EBIT growth, plus further margin expansion.
- Holcim emphasized value-accretive M&A, citing Xella and Pacasmayo, while saying leverage should return to around 1.6x by year-end.
Holcim reported H1 2026 organic net sales growth of 5.2% and Q2 organic net sales growth of 6.4%. Recurring EBIT grew 11.5% in H1 and 13.1% in Q2, while EPS increased 7.4% in Swiss francs year over year. Management said group margin in Q2 was flat versus the prior-year period, mainly due to divestments, and reiterated full-year free cash flow guidance of around CHF 2 billion. The company upgraded 2026 guidance to high end of its NextGen Growth 2030 targets: 5% organic net sales growth, 10% organic recurring EBIT growth, further recurring EBIT margin expansion, and continued above-proportional growth in recycled construction and demolition materials. Management also said leverage should be back to around 1.6x by year-end, close to the 1.5 target level, after the announced transactions and bolt-ons.
Miljan Gutovic framed the first half as a period of accelerating momentum, especially in Q2, and linked the outperformance to customer demand for sustainable offerings, strict cost discipline, and operational excellence. He stressed that Holcim’s strategy is centered on sustainable premium brands, circular construction, and value-accretive M&A, with Xella and Pacasmayo cited as examples that support NextGen Growth 2030. His tone was upbeat and confident, but he repeatedly tied the optimism to execution rather than broad macro assumptions.
Steffen Kindler focused on the mechanics behind growth and cash flow. He said organic sales growth represented almost CHF 390 million, recurring EBIT grew on the back of commercial execution and disciplined cost management, and foreign exchange translation effects softened in Q2; he also reiterated positive price over cost in all regions for the 17th consecutive quarter. On cash and capital allocation, he said free cash flow is still on track for around CHF 2 billion, leverage should return to around 1.6x by year-end, and the company remains committed to margin expansion, with Q2 flat year over year mainly because of divestments such as Nigeria.
Analysts pressed on Europe pricing, EU ETS changes, Latin American volumes and margins, corporate cost savings, Xella’s contribution, cash flow, and the balance sheet. Management said the EU ETS reforms look positive for Holcim and could create new opportunities in decarbonization, while pricing in Europe is already at mid-single digits and Q2 price over cost was positive by roughly EUR 90 million across all regions. On LatAm, management said margins should remain above 30% as a portfolio, with Pacasmayo integration causing some near-term dilution, and on cash flow and leverage it said the company remains confident in around CHF 2 billion of free cash flow and roughly 1.6x leverage by year-end despite acquisitions.
The bull case from the call is that Holcim is still compounding growth even in a mixed macro backdrop, with 5.2% H1 organic sales growth, 11.5% recurring EBIT growth, and positive price over cost for 17 straight quarters. Management also sounded confident that sustainable products, circular construction, AI initiatives, and M&A can keep supporting margin expansion and earnings growth.
The main risks flagged were uneven regional conditions, especially softer U.K. residential activity, Argentina softness, and election-related weakness in Colombia, plus near-term margin dilution from acquisitions and divestments. Management also acknowledged that it is too early to say whether Europe pricing will remain as strong in 2027, and cash flow guidance still depends on working capital, CapEx timing, and other period-specific items.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 18.2%
- Shares Outstanding
- 2.77B
- Float Shares
- 503.32M
of shares held by institutions
5 13F filers
Congressional trading
Senate and House stock disclosures for HCMLY, newest first.
| Member | Type | Traded | |
|---|---|---|---|
| Daniel GoldmanHouse · NY10 | Sell | Jul 10, 23 | Filing → |
Source: public STOCK Act disclosures. Filed weeks after the trade — a lagging signal, not a real-time one.
Held by 6 ETFs
Biggest fund positions in HCMLY by dollar value.
Our HCMLY coverage
Recent articles, reports, and earnings notes.
No research on HCMLY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HCMLY report →Holcim Ltd Unsponsored ADR (OTCMKTS:HCMLY) Stock Has Consensus Target Price of $16.80 According to Analysts
defenseworld.net · Sep 28
Holcim (OTCMKTS:HCMLY) Share Price Crosses Below 50 Day Moving Average – Time to Sell?
defenseworld.net · Sep 17
Holcim Ltd Unsponsored ADR (HCMLY) Upgraded to Buy: Here's Why
zacks.com · Sep 15
James Hardie Selling European Fermacell Business for $980 Million to Holcim
wsj.com · Aug 20
James Hardie Announces Strategic Divestiture of European Operations, Including Sale of Fermacell to Holcim for €840 Million
businesswire.com · Aug 20
HLMN vs. HCMLY: Which Stock Is the Better Value Option?
zacks.com · Aug 5
Head to Head Review: Great Lakes Dredge & Dock (NASDAQ:GLDD) & Holcim (OTCMKTS:HCMLY)
defenseworld.net · Aug 4
Holcim to sell majority stake in Philippines unit to China's Huaxin for $527 million
reuters.com · Aug 2
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.